Alpha 2.0
Login Register
» Articles » PMID: 35998976

Current Challenges and Perspectives on Developing a Clinical Trial Design for ADPKD

Overview
Journal Clin J Am Soc Nephrol
Specialty Nephrology
Date 2022 Aug 23
PMID 35998976
Authors
Craig Ostroff
Ronald D Perrone
Frank S Czerwiec
Affiliations
Soon will be listed here.
Citing Articles

Changes in tubular biomarkers with dietary intervention and metformin in patients with autosomal dominant polycystic kidney disease: a post-hoc analysis of two clinical trials.

Wang W, You Z, Steele C, Gitomer B, Chonchol M, Nowak K BMC Nephrol. 2024; 25(1):206.

PMID: 38918734 PMC: 11200847. DOI: 10.1186/s12882-024-03643-6.

Improved predictions of total kidney volume growth rate in ADPKD using two-parameter least squares fitting.

Hu Z, Sharbatdaran A, He X, Zhu C, Blumenfeld J, Rennert H Sci Rep. 2024; 14(1):13794.

PMID: 38877066 PMC: 11178802. DOI: 10.1038/s41598-024-62776-8.

Protocol for the nationwide registry of patients with polycystic kidney disease: japanese national registry of PKD (JRP).

Nakatani S, Kawano H, Sato M, Hoshino J, Nishio S, Miura K Clin Exp Nephrol. 2024; 28(10):1004-1015.

PMID: 38734869 DOI: 10.1007/s10157-024-02509-3.

Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry.

Hoover E, Holliday V, Merullo N, Oberdhan D, Perrone R, Rusconi C Kidney Med. 2024; 6(5):100813.

PMID: 38689835 PMC: 11059322. DOI: 10.1016/j.xkme.2024.100813.

Visceral Adiposity and Progression of ADPKD: A Cohort Study of Patients From the TEMPO 3:4 Trial.

Nowak K, Moretti F, Bussola N, Steele C, Gregory A, Kline T Am J Kidney Dis. 2024; 84(3):275-285.e1.

PMID: 38608748 PMC: 11344693. DOI: 10.1053/j.ajkd.2024.02.014.